148 related articles for article (PubMed ID: 33154047)
1. Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol.
Dieng M; Khanna N; Nguyen MTH; Turner R; Lord SJ; Menzies AM; Allen J; Saw R; Nieweg OE; Thompson J; Morton RL
BMJ Open; 2020 Nov; 10(11):e037857. PubMed ID: 33154047
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma.
Dieng M; Turner RM; Lord SJ; Einstein AJ; Menzies AM; Saw RPM; Nieweg OE; Thompson JF; Morton RL
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206519
[TBL] [Abstract][Full Text] [Related]
3. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL
Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma.
Dieng M; Cust AE; Kasparian NA; Butow P; Costa DS; Menzies SW; Mann GJ; Morton RL
BMJ Open; 2016 Oct; 6(10):e012153. PubMed ID: 27855094
[TBL] [Abstract][Full Text] [Related]
6. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
Nijhuis AAG; Dieng M; Khanna N; Lord SJ; Dalton J; Menzies AM; Turner RM; Allen J; Saw RPM; Nieweg OE; Thompson JF; Morton RL
Ann Surg Oncol; 2019 Jun; 26(6):1860-1868. PubMed ID: 30911946
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma.
Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E; Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S
Br J Dermatol; 2019 May; 180(5):1190-1197. PubMed ID: 29876940
[TBL] [Abstract][Full Text] [Related]
8. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
Rueth NM; Xing Y; Chiang YJ; Cromwell KD; Ross MI; Lee JE; Gershenwald JE; Royal RE; Cormier JN
Ann Surg; 2014 Jun; 259(6):1215-22. PubMed ID: 24096759
[TBL] [Abstract][Full Text] [Related]
9. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
[TBL] [Abstract][Full Text] [Related]
10. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
[TBL] [Abstract][Full Text] [Related]
11. The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma.
Ravichandran S; Nath N; Jones DC; Li G; Suresh V; Brys AK; Hanks BA; Beasley GM; Salama AKS; Howard BA; Mosca PJ
Surg Oncol; 2020 Dec; 35():533-539. PubMed ID: 33161362
[TBL] [Abstract][Full Text] [Related]
12. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.
Madu MF; Timmerman P; Wouters MWJM; van der Hiel B; van der Hage JA; van Akkooi ACJ
Melanoma Res; 2017 Jun; 27(3):251-257. PubMed ID: 28225434
[TBL] [Abstract][Full Text] [Related]
13. The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
Stahlie EHA; van der Hiel B; Stokkel MPM; Schrage YM; van Houdt WJ; Wouters MW; van Akkooi ACJ
J Surg Oncol; 2020 Dec; 122(7):1328-1336. PubMed ID: 32783266
[TBL] [Abstract][Full Text] [Related]
14. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
[TBL] [Abstract][Full Text] [Related]
15. The role of surveillance imaging for resected high-risk melanoma.
Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
[TBL] [Abstract][Full Text] [Related]
16. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
17. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
Twycross SH; Burger H; Holness J
S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864
[TBL] [Abstract][Full Text] [Related]
18. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.
Royce TJ; Punglia RS; Chen AB; Patel SA; Thornton KA; Raut CP; Baldini EH
Ann Surg Oncol; 2017 Oct; 24(11):3264-3270. PubMed ID: 28718037
[TBL] [Abstract][Full Text] [Related]
20. Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.
Lewin J; Sayers L; Kee D; Walpole I; Sanelli A; Te Marvelde L; Herschtal A; Spillane J; Gyorki D; Speakman D; Estall V; Donahoe S; Pohl M; Pope K; Chua M; Sandhu S; McArthur GA; McCormack CJ; Henderson M; Hicks RJ; Shackleton M
Ann Oncol; 2018 Jul; 29(7):1569-1574. PubMed ID: 29659679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
